Also, in aggressive breast cancer cell lines, the suppression of p53 expression leads to changes in the rRNA methylation pattern, impairing translational fidelity and enhancing the translation of key cancer-related genes, namely, IGF-1R, C-MYC, VEGF-A, and FGF1/2. This evidence concerns the gene TP53 and cancer.